Sweden · Growth startup

Who invested in InDex Pharmaceuticals

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$31Mraised across 2 rounds since 2011, from 2 sources

$11MGrowth$20MGrowth
Latest round
Growth, $20MFeb 2014
Step-upi
1.8×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011201220132014
$11MGrowth$20MGrowth
First round
Growth, $11M
Jan 2011
Biggest round
$20M
Growth · Feb 2014
Between rounds
3.1 years
from the last two

The rounds

  1. Feb 2014
    Growth$20M1 new2 returning

    From a historical funding record

  2. Jan 2011

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

IndustrifondenVC firm2rounds
SEB Venture CapitalVC firm2rounds
NeoMedGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about InDex Pharmaceuticals

Who invested in InDex Pharmaceuticals?

InDex Pharmaceuticals's investors include Industrifonden, SEB Venture Capital and NeoMed.

How much has InDex Pharmaceuticals raised?

InDex Pharmaceuticals has raised $31M across 2 rounds since 2011.

When did InDex Pharmaceuticals last raise?

InDex Pharmaceuticals's most recent round was a Growth of $20M in Feb 2014.

What was InDex Pharmaceuticals's biggest round?

Its most recent round, $20M in Feb 2014, is also its largest on record.

Who backed InDex Pharmaceuticals first?

InDex Pharmaceuticals's first round on record, in Jan 2011, was backed by Industrifonden and SEB Venture Capital.

What stage is InDex Pharmaceuticals at?

InDex Pharmaceuticals's latest named round is a Growth, in Feb 2014.

Where is InDex Pharmaceuticals based?

InDex Pharmaceuticals is based in Sweden.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.